Synthetic oligoribonucleotides containing arabinonucleotides act as agonists of TLR7 and 8 (original) (raw)
Stabilized immune modulatory RNA compounds as agonists of Toll-like receptors 7 and 8
Suraksha Agrawal
Proceedings of the National Academy of Sciences, 2007
View PDFchevron_right
Selection of molecular structure and delivery of RNA oligonucleotides to activate TLR7 versus TLR8 and to induce high amounts of IL-12p70 in primary human …
Stefan Endres
The Journal of …, 2009
View PDFchevron_right
Toll-like Receptor 7 Selective Synthetic Oligoribonucleotide Agonists: Synthesis and Structure−Activity Relationship Studies
Fugang Zhu
Journal of Medicinal Chemistry, 2009
View PDFchevron_right
Guanine-Modified Inhibitory Oligonucleotides Efficiently Impair TLR7- and TLR9-Mediated Immune Responses of Human Immune Cells
Hermann Wagner
PLOS ONE, 2015
View PDFchevron_right
2′-O-methyl-modified RNAs Act as TLR7 Antagonists
Ian MacLachlan
Molecular Therapy, 2007
View PDFchevron_right
Lipid-derived nanoparticles for immunostimulatory RNA adjuvant delivery
Kevin Love
Proceedings of the National Academy of Sciences, 2012
View PDFchevron_right
Nanoformulated Single‐Stranded RNA‐Based Adjuvant with a Coordinative Amphiphile as an Effective Stabilizer: Inducing Humoral Immune Response by Activation of Antigen‐Presenting Cells
Jae-ouk Kim
Angewandte Chemie International Edition, 2020
View PDFchevron_right
Bioconjugation of Small Molecules to RNA Impedes Its Recognition by Toll-Like Receptor 7
Dr. Salifu Seidu-Larry
Frontiers in Immunology, 2017
View PDFchevron_right
Oligodeoxynucleotides Modifiers and PolyT Imidazoquinoline Immune Response TLR8 by a Combination of Cutting Edge: Activation of Murine
John Vasilakos
2010
View PDFchevron_right
Nanoformulated ssRNA-based Adjuvant with a Coordinative Amphiphile as an Effective Stabilizer to Induce a Humoral Immune Response by Activation of Antigen-presenting Cells
Karim El Baz
Angewandte Chemie International Edition
View PDFchevron_right
Cutting Edge: Activation of Murine TLR8 by a Combination of Imidazoquinoline Immune Response Modifiers and PolyT Oligodeoxynucleotides
John Vasilakos
The Journal of Immunology, 2006
View PDFchevron_right
Synthetic immunostimulatory oligonucleotides in experimental and clinical practice
Janusz Kocik
Pharmacological Reports, 2012
View PDFchevron_right
Synthetic oligonucleotides as modulators of inflammation
Sven Klaschik
Journal of Leukocyte Biology, 2008
View PDFchevron_right
Therapeutic Applications and Mechanisms Underlying the Activity of Immunosuppressive Oligonucleotides
Sven Klaschik
Annals of the New York Academy of Sciences, 2009
View PDFchevron_right
Oligodeoxyribonucleotide-Based Antagonists for Toll-Like Receptors 7 and 9
jimmy tang
Journal of Medicinal Chemistry, 2009
View PDFchevron_right
Immunostimulatory RNA Oligonucleotides Induce an Effective Antitumoral NK Cell Response through the TLR7
Hendrik Poeck, Carole Bourquin
The Journal of Immunology, 2009
View PDFchevron_right
Recent advances in the development of immunostimulatory oligonucleotides
Eugen Uhlmann
View PDFchevron_right
Design of synthetic oligoribonucleotide-based agonists of Toll-like receptor 3 and their immune response profiles in vitro and in vivo
Mallikarjuna Putta
Organic & Biomolecular Chemistry, 2013
View PDFchevron_right
Modifications Incorporated in CpG Motifs of Oligodeoxynucleotides Lead to Antagonist Activity of Toll-like Receptors 7 and 9
Fugang Zhu
Journal of Medicinal Chemistry, 2009
View PDFchevron_right
Single-stranded DNA oligonucleotides inhibit TLR3-mediated responses in human monocyte-derived dendritic cells and in vivo in cynomolgus macaques
Roger Grand
Blood, 2012
View PDFchevron_right
Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans
Sarah Schlesinger
The Journal of experimental medicine, 2011
View PDFchevron_right
Drug Delivery–mediated Control of RNA Immunostimulation
Svetlana Shulga-Morskaya, Tatiana Novobrantseva
Molecular Therapy, 2009
View PDFchevron_right
Rna & Oligonucleotide Therapeutics
Ryszard Kole
2010
View PDFchevron_right
Immunostimulatory RNA is a potent inducer of antigen-specific cytotoxic and humoral immune response in vivo
Svetlana Hamm
International Immunology, 2007
View PDFchevron_right
RNA to the rescue: RNA is one of the most promising targets for drug development given its wide variety of uses
Andrea C. Rinaldi
EMBO reports, 2020
View PDFchevron_right
Novel oligodeoxynucleotide agonists of TLR9 containing N3-Me-dC or N1-Me-dG modifications
Mallikarjuna Putta
2006
View PDFchevron_right
Immunomodulatory oligonucleotides containing a cytosine-phosphate-2′-deoxy-7-deazaguanosine motif as potent Toll-like receptor 9 agonists
jimmy tang
Proceedings of the National Academy of Sciences, 2005
View PDFchevron_right
Characterization of suppressive oligodeoxynucleotides that inhibit Toll‐like receptor‐9‐mediated activation of innate immunity
Konrad Bode
Immunology, 2008
View PDFchevron_right
Immune-Stimulatory Dinucleotide at the 5′-End of Oligodeoxynucleotides Is Critical for TLR9-Mediated Immune Responses
Mallikarjuna Putta
ACS Medicinal Chemistry Letters, 2013
View PDFchevron_right
Immunogenicity Testing of Lipidoids In Vitro and In Silico: Modulating Lipidoid-Mediated TLR4 Activation by Nanoparticle Design
Camilla Foged
View PDFchevron_right